Leslie A Pierce
CIK 1402176 · View on SEC EDGAR ↗
First SEC filing: Feb. 16, 2010 · Latest: Feb. 16, 2010
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Feb. 14, 2010 | DBD | F | 92 | $28.04 | $2,580 | 3,877 Direct | -2.32% | Disposed | 140.3% (price as of 2026-08-20) |
| Feb. 11, 2010 | DBD | A | 1,250 | — | — | 1,969 Direct | +173.85% | Acquired | (price as of 2026-08-20) |
| Feb. 11, 2010 | DBD | A | 2,000 | — | — | 3,969 Direct | +101.57% | Acquired | (price as of 2026-08-20) |
| Feb. 11, 2010 | DBD | A | 8,000 | $27.88 | $223,040 | 8,000 Direct | — | Acquired | 141.7% (price as of 2026-08-20) |
| Feb. 20, 2009 | DBD | F | 143 | $22.96 | $3,283 | 719 Direct | -16.59% | Disposed | 193.5% (price as of 2026-08-20) |
| Feb. 11, 2009 | DBD | A | 7,000 | $24.79 | $173,530 | 7,000 Direct | — | Acquired | 171.8% (price as of 2026-08-20) |
| Feb. 13, 2008 | DBD | A | 5,000 | $25.53 | $127,650 | 5,000 Direct | — | Acquired | 164.0% (price as of 2026-08-20) |
| Feb. 10, 2008 | DBD | F | 41 | $25.49 | $1,045 | 1,017 Direct | -3.88% | Disposed | 164.4% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 11, 2010 | DBD | Non-qualified Stock Option [F7] | Common Stock (8,000) | $27.88 | Feb. 10, 2020 | 8,000 | Acquired |
| Feb. 11, 2009 | DBD | Non-qualified Stock Option [F4] | Common Stock (7,000) | $24.79 | Feb. 10, 2019 | 7,000 | Acquired |
| Feb. 13, 2008 | DBD | Non-qualified Stock Option [F3] | Common Stock (5,000) | $25.53 | Feb. 12, 2018 | 5,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
DBD
President and Corporate Controller| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2012 | $75,808 | — | — | — | — | — | $1,250,869 | $1,557,620 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.